Phase 2
๐ Investigational Drug / Biologic
NCT06067438
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
๐ OHSU Knight Cancer Institute โ Portland, Oregon
View Study & Screener โ